145 related articles for article (PubMed ID: 33116584)
21. GAS5 Regulates RECK Expression and Inhibits Invasion Potential of HCC Cells by Sponging miR-135b.
Yang L; Jiang J
Biomed Res Int; 2019; 2019():2973289. PubMed ID: 30733959
[TBL] [Abstract][Full Text] [Related]
22. MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1.
Li Y; Bai W; Zhang J
Biomed Pharmacother; 2017 Aug; 92():1038-1044. PubMed ID: 28609841
[TBL] [Abstract][Full Text] [Related]
23. Lnc SMAD5-AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt/β-catenin pathway by sponging miR-135b-5p to elevate expression of APC.
Zhao CC; Jiao Y; Zhang YY; Ning J; Zhang YR; Xu J; Wei W; Kang-Sheng G
Cell Death Dis; 2019 Mar; 10(4):252. PubMed ID: 30874550
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY
J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163
[TBL] [Abstract][Full Text] [Related]
25. Long Noncoding RNA
Gong X; Zhu Z
Cancer Biother Radiopharm; 2020 Jun; 35(5):387-396. PubMed ID: 32315535
[No Abstract] [Full Text] [Related]
26. Repression of the miR-627-5p by histone deacetylase 3 contributes to hypoxia-induced hepatocellular carcinoma progression.
Wang J; Liu R; Wang Y; Mo H; Niu Y; Xu Q; Liu Q
J Cancer; 2021; 12(17):5320-5330. PubMed ID: 34335948
[TBL] [Abstract][Full Text] [Related]
27. Olaparib and enzalutamide synergistically suppress HCC progression via the AR-mediated miR-146a-5p/BRCA1 signaling.
Zhao J; Sun Y; Lin H; Chou F; Xiao Y; Jin R; Cai X; Chang C
FASEB J; 2020 Apr; 34(4):5877-5891. PubMed ID: 32134529
[TBL] [Abstract][Full Text] [Related]
28. miR-493-5p suppresses hepatocellular carcinoma cell proliferation through targeting GP73.
Zhao J; Xu T; Wang F; Cai W; Chen L
Biomed Pharmacother; 2017 Jun; 90():744-751. PubMed ID: 28419971
[TBL] [Abstract][Full Text] [Related]
29. Up-regulation of
Wu G; Ju X; Wang Y; Li Z; Gan X
Cell Cycle; 2019 Aug; 18(16):1849-1867. PubMed ID: 31258024
[TBL] [Abstract][Full Text] [Related]
30. CircZKSCAN1 Suppresses Hepatocellular Carcinoma Tumorigenesis by Regulating miR-873-5p/Downregulation of Deleted in Liver Cancer 1.
Li J; Bao S; Wang L; Wang R
Dig Dis Sci; 2021 Dec; 66(12):4374-4383. PubMed ID: 33439397
[TBL] [Abstract][Full Text] [Related]
31. Abnormal expression of miR-135b-5p in bone tissue of patients with osteoporosis and its role and mechanism in osteoporosis progression.
Chen B; Yang W; Zhao H; Liu K; Deng A; Zhang G; Pan K
Exp Ther Med; 2020 Feb; 19(2):1042-1050. PubMed ID: 32010267
[TBL] [Abstract][Full Text] [Related]
32. The miR-367-3p Increases Sorafenib Chemotherapy Efficacy to Suppress Hepatocellular Carcinoma Metastasis through Altering the Androgen Receptor Signals.
Xu J; Lin H; Li G; Sun Y; Chen J; Shi L; Cai X; Chang C
EBioMedicine; 2016 Oct; 12():55-67. PubMed ID: 27688096
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
[TBL] [Abstract][Full Text] [Related]
34. MiR-135b-5p promotes viability, proliferation, migration and invasion of gastric cancer cells by targeting Krüppel-like factor 4 (KLF4).
Chen Z; Gao Y; Gao S; Song D; Feng Y
Arch Med Sci; 2020; 16(1):167-176. PubMed ID: 32051721
[TBL] [Abstract][Full Text] [Related]
35. Protein tyrosine phosphatase non-receptor type 12 (PTPN12), negatively regulated by miR-106a-5p, suppresses the progression of hepatocellular carcinoma.
Liang Z; Li X; Duan F; Song L; Wang Z; Li X; Yang P; Li L
Hum Cell; 2022 Jan; 35(1):299-309. PubMed ID: 34784010
[TBL] [Abstract][Full Text] [Related]
36. miR-17-5p and miR-20a-5p suppress postoperative metastasis of hepatocellular carcinoma via blocking HGF/ERBB3-NF-κB positive feedback loop.
Liu DL; Lu LL; Dong LL; Liu Y; Bian XY; Lian BF; Xie L; Wen D; Gao DM; Ke AW; Fan J; Wu WZ
Theranostics; 2020; 10(8):3668-3683. PubMed ID: 32206115
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of circDYNC1H1 exhibits inhibitor effect on cell proliferation and migration in hepatocellular carcinoma through miR-140-5p.
Wang ZY; Zhu Z; Wang HF; Qin B; Liu J; Yao XH; Li WC; Chen KS
J Cell Physiol; 2019 Aug; 234(10):17775-17785. PubMed ID: 30864145
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-135b-5p prevents oxygen-glucose deprivation and reoxygenation-induced neuronal injury through regulation of the GSK-3β/Nrf2/ARE signaling pathway.
Duan Q; Sun W; Yuan H; Mu X
Arch Med Sci; 2018 Jun; 14(4):735-744. PubMed ID: 30002689
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of miR-135b-5p promotes unfavorable clinical characteristics and poor prognosis via the repression of SFRP4 in pancreatic cancer.
Han X; Saiyin H; Zhao J; Fang Y; Rong Y; Shi C; Lou W; Kuang T
Oncotarget; 2017 Sep; 8(37):62195-62207. PubMed ID: 28977937
[TBL] [Abstract][Full Text] [Related]
40. LncRNA HCG11 accelerates the progression of hepatocellular carcinoma via miR-26a-5p/ATG12 axis.
Li ML; Zhang Y; Ma LT
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10708-10720. PubMed ID: 31858580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
